Mitiperstat

N/A

Report date: 2023/04/04 16:45:35
NME

Base Information

Drug NameMitiperstat
Drug Alias NameAZD-4831
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyeloperoxidase inhibitors
TargetsMyeloperoxidase
Therapy Area/IndicationsHeart Failure, DiastolicHeart FailureCardiovascular Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[25] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesNational Center For Advancing Translational SciencesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsHeart Failure, DiastolicHeart FailurePulmonary Disease, Chronic Obstructive +[4] 
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A